Security key
G7709Q104
Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (RPRX)
CUSIP: G7709Q104
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / Class A Ordinary Shares, par value $0.0001 per share
- Total 13F shares
- 320,707,173
- Total 13F value
- $8,183,523,072
- Share change
- +6,055,853
- Put/Call ratio
- 23%
- SEC-reported price per share
- $25.51
- Number of holders
- 414
- Value change
- +$144,649,409
- Number of buys
- 214
- Number of sells
- 185
- Shares outstanding
- 424,966,351
Holder snapshot
7 signals
Show 1 more signal
Security identity
1 source field
Report period
Q4 2024
Institutions
414
Top holders
10
RPRX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2025
Previous quarter: Q3 2024
Royalty Pharma plc SEC filings
Royalty Pharma plc company facts
Broader feeds
Reporting periods
Holder history for CUSIP G7709Q104
Recent filing periods:
Ownership snapshot
Top reported holders of RPRX - Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock, Inc.
Disclosed value leader
MORGAN STANLEY
Comparable rows
15/15
Latest evidence
31 Dec 2024
13D/G
13F
Lead comparable stake: 5.7%
13D/G row: BlackRock, Inc.
Showing 1-6 of 15 holder rows.
Quick read
BlackRock, Inc. leads the comparable SEC ownership view at 5.7%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
BlackRock, Inc.
5.7%
MORGAN STANLEY
9.7%
VANGUARD GROUP INC
8.8%
FMR LLC
6.6%
BAILLIE GIFFORD & CO
3.8%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock, Inc. |
13D/G
13F
Company
|
5.7%
|
$832,319,492
25,445,414 shares
|
$0 | 31 Dec 2024 |
| MORGAN STANLEY |
13F
Company
|
9.7%
|
$1,162,101,308
41,078,163 shares
|
— | 30 Sep 2024 |
| VANGUARD GROUP INC |
13F
Company
|
8.8%
|
$1,063,283,130
37,585,123 shares
|
— | 30 Sep 2024 |
| FMR LLC |
13F
Company
|
6.6%
|
$789,012,140
27,890,143 shares
|
— | 30 Sep 2024 |
| BAILLIE GIFFORD & CO |
13F
Company
|
3.8%
|
$456,105,271
16,122,491 shares
|
— | 30 Sep 2024 |
| VIKING GLOBAL INVESTORS LP |
13F
Company
|
2.8%
|
$342,139,854
12,094,021 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
414
Shares
320,707,173
Rows available
414
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
391
Q4 2024 holders
414
Holder diff
23
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend